Wexler Wallace LLP is actively pursuing cases against GlaxoSmithKline, the manufacturer of the prescription drug Zofran (Ondansetron).
Zofran is an anti-nausea medication approved for use by the FDA to treat nausea post-operatively and in patients undergoing cancer therapy. Though never approved for use during pregnancy, Zofran has been extensively promoted and marketed for off-label use to treat women experiencing morning sickness. Due to this off-label promotion, thousands of women have taken Zofran during their first trimester of pregnancy, an extremely significant time of fetal development.
Recent clinical studies have raised concerns over Zofran’s safety and have linked Zofran use during the first trimester to birth defects such as cleft lip, cleft palate and cardiac malformations. If you took Zofran during pregnancy and your child suffered health complications, please contact us at 312.346.2222 for more information, or complete our online form. We maintain the confidentiality of all inquiries and information provided.